Dr. Ryan Zarychanski News Archive
November 17, 2023 —
The Max Rady College of Medicine at UM is marking a milestone. It’s been 140 years since it was founded in 1883 as the Manitoba Medical College, Western Canada’s first medical school.
March 10, 2023 —
The UM medical school is well represented on this year’s list of Doctors Manitoba Award winners.
January 19, 2023 —
A scientist from the University of Manitoba has been awarded a national training network to help prepare the next generation of researchers to run clinical trials in the areas of pregnancy and pediatrics.
November 28, 2022 —
Six studies led by Rady Faculty of Health Sciences researchers received nearly $7 million in funding from the Canadian Institutes of Health Research (CIHR).
August 4, 2021 —
Collaborative international clinical trials testing full-dose anticoagulation with heparin (a blood thinner) in hospitalized patients with COVID-19 has found the treatment improves survival and reduces the need for vital organ support such as mechanical ventilation in moderately ill patients
March 1, 2021 —
A University of Manitoba research team is emerging as a global leader in COVID-19 anticoagulation trials thanks to their innovative, global trial studying different types of heparin, an anticoagulant (blood thinning) and anti-inflammatory drug
Full-dose blood thinners decreased need for life support and improved outcomes in hospitalized COVID-19 patients in international trial
January 22, 2021 —
Treatment expected to reduce the pressure in intensive care units around the world
December 22, 2020 —
Three clinical trial platforms working together to test the effects of full doses of anticoagulants (blood thinners) in COVID-19 patients have paused enrollment for one group of patients.
June 25, 2020 —
Six University of Manitoba researchers and their teams have received $7.5 million in federal and provincial funding to investigate a range of impacts of the virus on specific populations
June 3, 2020 —
A study published in the prestigious New England Journal of Medicine has found that the drug hydroxychloroquine does not prevent infection from COVID-19.